nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Insomnia—Irinotecan—pancreatic cancer	0.00112	0.00184	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Docetaxel—pancreatic cancer	0.00112	0.00184	CcSEcCtD
Glycopyrrolate—Flushing—Docetaxel—pancreatic cancer	0.00112	0.00184	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Epirubicin—pancreatic cancer	0.00112	0.00184	CcSEcCtD
Glycopyrrolate—Vomiting—Tamoxifen—pancreatic cancer	0.00112	0.00183	CcSEcCtD
Glycopyrrolate—Mood swings—Epirubicin—pancreatic cancer	0.00111	0.00183	CcSEcCtD
Glycopyrrolate—Hypotension—Fluorouracil—pancreatic cancer	0.00111	0.00182	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Sunitinib—pancreatic cancer	0.00111	0.00182	CcSEcCtD
Glycopyrrolate—Rash—Tamoxifen—pancreatic cancer	0.00111	0.00182	CcSEcCtD
Glycopyrrolate—Dermatitis—Tamoxifen—pancreatic cancer	0.00111	0.00182	CcSEcCtD
Glycopyrrolate—Vomiting—Erlotinib—pancreatic cancer	0.0011	0.00181	CcSEcCtD
Glycopyrrolate—Somnolence—Irinotecan—pancreatic cancer	0.0011	0.00181	CcSEcCtD
Glycopyrrolate—Headache—Tamoxifen—pancreatic cancer	0.0011	0.00181	CcSEcCtD
Glycopyrrolate—Rash—Erlotinib—pancreatic cancer	0.00109	0.0018	CcSEcCtD
Glycopyrrolate—Dermatitis—Erlotinib—pancreatic cancer	0.00109	0.0018	CcSEcCtD
Glycopyrrolate—Dehydration—Epirubicin—pancreatic cancer	0.00109	0.0018	CcSEcCtD
Glycopyrrolate—Insomnia—Gemcitabine—pancreatic cancer	0.00109	0.00179	CcSEcCtD
Glycopyrrolate—Dyspepsia—Irinotecan—pancreatic cancer	0.00109	0.00179	CcSEcCtD
Glycopyrrolate—Headache—Erlotinib—pancreatic cancer	0.00109	0.00179	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—pancreatic cancer	0.00109	0.00179	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00109	0.00178	CcSEcCtD
Glycopyrrolate—Asthenia—Sunitinib—pancreatic cancer	0.00108	0.00177	CcSEcCtD
Glycopyrrolate—Dry skin—Epirubicin—pancreatic cancer	0.00108	0.00177	CcSEcCtD
Glycopyrrolate—Insomnia—Fluorouracil—pancreatic cancer	0.00107	0.00176	CcSEcCtD
Glycopyrrolate—Somnolence—Gemcitabine—pancreatic cancer	0.00107	0.00176	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—pancreatic cancer	0.00107	0.00176	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00107	0.00176	CcSEcCtD
Glycopyrrolate—Fatigue—Irinotecan—pancreatic cancer	0.00107	0.00175	CcSEcCtD
Glycopyrrolate—Pruritus—Sunitinib—pancreatic cancer	0.00106	0.00175	CcSEcCtD
Glycopyrrolate—Pain—Irinotecan—pancreatic cancer	0.00106	0.00174	CcSEcCtD
Glycopyrrolate—Constipation—Irinotecan—pancreatic cancer	0.00106	0.00174	CcSEcCtD
Glycopyrrolate—Mental disorder—Docetaxel—pancreatic cancer	0.00106	0.00173	CcSEcCtD
Glycopyrrolate—Somnolence—Fluorouracil—pancreatic cancer	0.00105	0.00173	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00105	0.00173	CcSEcCtD
Glycopyrrolate—Erythema—Docetaxel—pancreatic cancer	0.00105	0.00172	CcSEcCtD
Glycopyrrolate—Malnutrition—Docetaxel—pancreatic cancer	0.00105	0.00172	CcSEcCtD
Glycopyrrolate—Dyspepsia—Fluorouracil—pancreatic cancer	0.00104	0.00172	CcSEcCtD
Glycopyrrolate—Nausea—Tamoxifen—pancreatic cancer	0.00104	0.00171	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00104	0.00171	CcSEcCtD
Glycopyrrolate—Fatigue—Gemcitabine—pancreatic cancer	0.00104	0.00171	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00103	0.0017	CcSEcCtD
Glycopyrrolate—Pain—Gemcitabine—pancreatic cancer	0.00103	0.00169	CcSEcCtD
Glycopyrrolate—Constipation—Gemcitabine—pancreatic cancer	0.00103	0.00169	CcSEcCtD
Glycopyrrolate—Nausea—Erlotinib—pancreatic cancer	0.00103	0.00169	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—pancreatic cancer	0.00103	0.00169	CcSEcCtD
Glycopyrrolate—Dysgeusia—Docetaxel—pancreatic cancer	0.00103	0.00169	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00102	0.00168	CcSEcCtD
Glycopyrrolate—Abdominal distension—Epirubicin—pancreatic cancer	0.00102	0.00168	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Irinotecan—pancreatic cancer	0.00102	0.00168	CcSEcCtD
Glycopyrrolate—Pain—Fluorouracil—pancreatic cancer	0.00101	0.00167	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00101	0.00166	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—pancreatic cancer	0.00101	0.00166	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—pancreatic cancer	0.000996	0.00164	CcSEcCtD
Glycopyrrolate—Dizziness—Sunitinib—pancreatic cancer	0.000994	0.00163	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000994	0.00163	CcSEcCtD
Glycopyrrolate—Abdominal pain—Irinotecan—pancreatic cancer	0.000979	0.00161	CcSEcCtD
Glycopyrrolate—Body temperature increased—Irinotecan—pancreatic cancer	0.000979	0.00161	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000977	0.00161	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000972	0.0016	CcSEcCtD
Glycopyrrolate—Vomiting—Sunitinib—pancreatic cancer	0.000956	0.00157	CcSEcCtD
Glycopyrrolate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000954	0.00157	CcSEcCtD
Glycopyrrolate—Dysuria—Epirubicin—pancreatic cancer	0.000949	0.00156	CcSEcCtD
Glycopyrrolate—Rash—Sunitinib—pancreatic cancer	0.000948	0.00156	CcSEcCtD
Glycopyrrolate—Dermatitis—Sunitinib—pancreatic cancer	0.000947	0.00156	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000946	0.00155	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000944	0.00155	CcSEcCtD
Glycopyrrolate—Urticaria—Fluorouracil—pancreatic cancer	0.000942	0.00155	CcSEcCtD
Glycopyrrolate—Headache—Sunitinib—pancreatic cancer	0.000942	0.00155	CcSEcCtD
Glycopyrrolate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000938	0.00154	CcSEcCtD
Glycopyrrolate—Palpitations—Docetaxel—pancreatic cancer	0.000927	0.00152	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000916	0.0015	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000912	0.0015	CcSEcCtD
Glycopyrrolate—Pneumonia—Epirubicin—pancreatic cancer	0.000911	0.0015	CcSEcCtD
Glycopyrrolate—Convulsion—Docetaxel—pancreatic cancer	0.000909	0.00149	CcSEcCtD
Glycopyrrolate—Hypertension—Docetaxel—pancreatic cancer	0.000906	0.00149	CcSEcCtD
Glycopyrrolate—Infestation—Epirubicin—pancreatic cancer	0.000905	0.00149	CcSEcCtD
Glycopyrrolate—Drowsiness—Epirubicin—pancreatic cancer	0.000905	0.00149	CcSEcCtD
Glycopyrrolate—Infestation NOS—Epirubicin—pancreatic cancer	0.000905	0.00149	CcSEcCtD
Glycopyrrolate—Nausea—Sunitinib—pancreatic cancer	0.000893	0.00147	CcSEcCtD
Glycopyrrolate—Asthenia—Irinotecan—pancreatic cancer	0.000888	0.00146	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000887	0.00146	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Epirubicin—pancreatic cancer	0.00088	0.00145	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—pancreatic cancer	0.000878	0.00144	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000874	0.00144	CcSEcCtD
Glycopyrrolate—Dry mouth—Docetaxel—pancreatic cancer	0.000873	0.00143	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000873	0.00143	CcSEcCtD
Glycopyrrolate—Sweating—Epirubicin—pancreatic cancer	0.000868	0.00143	CcSEcCtD
Glycopyrrolate—Asthenia—Gemcitabine—pancreatic cancer	0.000865	0.00142	CcSEcCtD
Glycopyrrolate—Confusional state—Docetaxel—pancreatic cancer	0.000863	0.00142	CcSEcCtD
Glycopyrrolate—Oedema—Docetaxel—pancreatic cancer	0.000856	0.00141	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000856	0.00141	CcSEcCtD
Glycopyrrolate—Epistaxis—Epirubicin—pancreatic cancer	0.000854	0.0014	CcSEcCtD
Glycopyrrolate—Pruritus—Gemcitabine—pancreatic cancer	0.000853	0.0014	CcSEcCtD
Glycopyrrolate—Infection—Docetaxel—pancreatic cancer	0.00085	0.0014	CcSEcCtD
Glycopyrrolate—Sinusitis—Epirubicin—pancreatic cancer	0.000849	0.0014	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000847	0.00139	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—pancreatic cancer	0.000843	0.00138	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000839	0.00138	CcSEcCtD
Glycopyrrolate—Pruritus—Fluorouracil—pancreatic cancer	0.000839	0.00138	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—pancreatic cancer	0.000838	0.00138	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000838	0.00138	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—pancreatic cancer	0.000838	0.00138	CcSEcCtD
Glycopyrrolate—Tachycardia—Docetaxel—pancreatic cancer	0.000835	0.00137	CcSEcCtD
Glycopyrrolate—Skin disorder—Docetaxel—pancreatic cancer	0.000831	0.00137	CcSEcCtD
Glycopyrrolate—Dizziness—Irinotecan—pancreatic cancer	0.000819	0.00135	CcSEcCtD
Glycopyrrolate—Rhinitis—Epirubicin—pancreatic cancer	0.000815	0.00134	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000814	0.00134	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000809	0.00133	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—pancreatic cancer	0.000803	0.00132	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000803	0.00132	CcSEcCtD
Glycopyrrolate—Hypotension—Docetaxel—pancreatic cancer	0.0008	0.00131	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000799	0.00131	CcSEcCtD
Glycopyrrolate—Urethral disorder—Epirubicin—pancreatic cancer	0.000797	0.00131	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—pancreatic cancer	0.00079	0.0013	CcSEcCtD
Glycopyrrolate—Vomiting—Irinotecan—pancreatic cancer	0.000787	0.00129	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—pancreatic cancer	0.000786	0.00129	CcSEcCtD
Glycopyrrolate—Dizziness—Fluorouracil—pancreatic cancer	0.000784	0.00129	CcSEcCtD
Glycopyrrolate—Rash—Irinotecan—pancreatic cancer	0.000781	0.00128	CcSEcCtD
Glycopyrrolate—Dermatitis—Irinotecan—pancreatic cancer	0.00078	0.00128	CcSEcCtD
Glycopyrrolate—Headache—Irinotecan—pancreatic cancer	0.000776	0.00127	CcSEcCtD
Glycopyrrolate—Insomnia—Docetaxel—pancreatic cancer	0.000774	0.00127	CcSEcCtD
Glycopyrrolate—Vomiting—Gemcitabine—pancreatic cancer	0.000767	0.00126	CcSEcCtD
Glycopyrrolate—Somnolence—Docetaxel—pancreatic cancer	0.000761	0.00125	CcSEcCtD
Glycopyrrolate—Rash—Gemcitabine—pancreatic cancer	0.000761	0.00125	CcSEcCtD
Glycopyrrolate—Dermatitis—Gemcitabine—pancreatic cancer	0.00076	0.00125	CcSEcCtD
Glycopyrrolate—Headache—Gemcitabine—pancreatic cancer	0.000756	0.00124	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000754	0.00124	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—pancreatic cancer	0.000754	0.00124	CcSEcCtD
Glycopyrrolate—Vomiting—Fluorouracil—pancreatic cancer	0.000754	0.00124	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—pancreatic cancer	0.000754	0.00124	CcSEcCtD
Glycopyrrolate—Dyspepsia—Docetaxel—pancreatic cancer	0.000754	0.00124	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000748	0.00123	CcSEcCtD
Glycopyrrolate—Rash—Fluorouracil—pancreatic cancer	0.000748	0.00123	CcSEcCtD
Glycopyrrolate—Dermatitis—Fluorouracil—pancreatic cancer	0.000747	0.00123	CcSEcCtD
Glycopyrrolate—Headache—Fluorouracil—pancreatic cancer	0.000743	0.00122	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000743	0.00122	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000739	0.00121	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000739	0.00121	CcSEcCtD
Glycopyrrolate—Fatigue—Docetaxel—pancreatic cancer	0.000738	0.00121	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000737	0.00121	CcSEcCtD
Glycopyrrolate—Nausea—Irinotecan—pancreatic cancer	0.000736	0.00121	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000732	0.0012	CcSEcCtD
Glycopyrrolate—Pain—Docetaxel—pancreatic cancer	0.000732	0.0012	CcSEcCtD
Glycopyrrolate—Constipation—Docetaxel—pancreatic cancer	0.000732	0.0012	CcSEcCtD
Glycopyrrolate—Nausea—Gemcitabine—pancreatic cancer	0.000716	0.00118	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—pancreatic cancer	0.000712	0.00117	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—pancreatic cancer	0.000707	0.00116	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—pancreatic cancer	0.000707	0.00116	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000705	0.00116	CcSEcCtD
Glycopyrrolate—Nausea—Fluorouracil—pancreatic cancer	0.000704	0.00116	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0007	0.00115	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—pancreatic cancer	0.000698	0.00115	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000698	0.00115	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—pancreatic cancer	0.000697	0.00115	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—pancreatic cancer	0.000694	0.00114	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—pancreatic cancer	0.000693	0.00114	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—pancreatic cancer	0.000687	0.00113	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000678	0.00111	CcSEcCtD
Glycopyrrolate—Abdominal pain—Docetaxel—pancreatic cancer	0.000677	0.00111	CcSEcCtD
Glycopyrrolate—Body temperature increased—Docetaxel—pancreatic cancer	0.000677	0.00111	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—pancreatic cancer	0.000667	0.0011	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—pancreatic cancer	0.000659	0.00108	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—pancreatic cancer	0.000655	0.00108	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—pancreatic cancer	0.000655	0.00108	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—pancreatic cancer	0.00065	0.00107	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—pancreatic cancer	0.000645	0.00106	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—pancreatic cancer	0.000642	0.00106	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000641	0.00105	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—pancreatic cancer	0.000636	0.00104	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000631	0.00104	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—pancreatic cancer	0.000625	0.00103	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—pancreatic cancer	0.000617	0.00101	CcSEcCtD
Glycopyrrolate—Asthenia—Docetaxel—pancreatic cancer	0.000614	0.00101	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—pancreatic cancer	0.000613	0.00101	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—pancreatic cancer	0.000611	0.001	CcSEcCtD
Glycopyrrolate—Pruritus—Docetaxel—pancreatic cancer	0.000606	0.000995	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—pancreatic cancer	0.000602	0.000988	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000598	0.000983	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—pancreatic cancer	0.000589	0.000968	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—pancreatic cancer	0.000582	0.000957	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—pancreatic cancer	0.000578	0.00095	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—pancreatic cancer	0.000577	0.000949	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000577	0.000949	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—pancreatic cancer	0.000574	0.000942	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—pancreatic cancer	0.000567	0.000932	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000566	0.00093	CcSEcCtD
Glycopyrrolate—Dizziness—Docetaxel—pancreatic cancer	0.000566	0.00093	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—pancreatic cancer	0.000565	0.000929	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—pancreatic cancer	0.000564	0.000926	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—pancreatic cancer	0.000561	0.000921	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000558	0.000917	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000553	0.000909	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—pancreatic cancer	0.000545	0.000896	CcSEcCtD
Glycopyrrolate—Vomiting—Docetaxel—pancreatic cancer	0.000544	0.000894	CcSEcCtD
Glycopyrrolate—Rash—Docetaxel—pancreatic cancer	0.00054	0.000887	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—pancreatic cancer	0.00054	0.000886	CcSEcCtD
Glycopyrrolate—Dermatitis—Docetaxel—pancreatic cancer	0.000539	0.000886	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—pancreatic cancer	0.000539	0.000885	CcSEcCtD
Glycopyrrolate—Headache—Docetaxel—pancreatic cancer	0.000536	0.000881	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—pancreatic cancer	0.000534	0.000878	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000534	0.000878	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—pancreatic cancer	0.000531	0.000872	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000524	0.000861	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—pancreatic cancer	0.000522	0.000858	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—pancreatic cancer	0.000521	0.000857	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—pancreatic cancer	0.000519	0.000853	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000516	0.000849	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—pancreatic cancer	0.000513	0.000843	CcSEcCtD
Glycopyrrolate—Nausea—Docetaxel—pancreatic cancer	0.000508	0.000835	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—pancreatic cancer	0.000508	0.000835	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—pancreatic cancer	0.000499	0.00082	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000498	0.000819	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—pancreatic cancer	0.000498	0.000818	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—pancreatic cancer	0.000494	0.000811	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—pancreatic cancer	0.000494	0.000811	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—pancreatic cancer	0.000483	0.000794	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000476	0.000782	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—pancreatic cancer	0.000475	0.00078	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000472	0.000776	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—pancreatic cancer	0.00047	0.000773	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000461	0.000758	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—pancreatic cancer	0.000461	0.000757	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—pancreatic cancer	0.000459	0.000754	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—pancreatic cancer	0.000457	0.000751	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—pancreatic cancer	0.000457	0.000751	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—pancreatic cancer	0.000456	0.00075	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—pancreatic cancer	0.000456	0.00075	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00044	0.000723	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000437	0.000718	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000425	0.000699	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—pancreatic cancer	0.000424	0.000697	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000422	0.000694	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000422	0.000694	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—pancreatic cancer	0.000414	0.000681	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—pancreatic cancer	0.000408	0.000671	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000394	0.000647	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—pancreatic cancer	0.000383	0.00063	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—pancreatic cancer	0.000382	0.000627	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—pancreatic cancer	0.000378	0.000621	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—pancreatic cancer	0.000367	0.000603	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—pancreatic cancer	0.000364	0.000598	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—pancreatic cancer	0.000364	0.000598	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—pancreatic cancer	0.000362	0.000594	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—pancreatic cancer	0.000353	0.00058	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—pancreatic cancer	0.000343	0.000563	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—pancreatic cancer	0.00034	0.000558	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—pancreatic cancer	0.000337	0.000553	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—pancreatic cancer	0.000337	0.000553	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—pancreatic cancer	0.000335	0.00055	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—pancreatic cancer	0.000317	0.000521	CcSEcCtD
Glycopyrrolate—CHRM1—Signaling Pathways—SST—pancreatic cancer	0.0001	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—STK11—pancreatic cancer	0.0001	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SST—pancreatic cancer	0.0001	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SST—pancreatic cancer	9.92e-05	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.91e-05	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.88e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	9.83e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—pancreatic cancer	9.83e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	9.8e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CB—pancreatic cancer	9.79e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	9.79e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	9.78e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	9.76e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	9.71e-05	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	9.67e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	9.41e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TERT—pancreatic cancer	9.36e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	9.27e-05	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	9.24e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	9.15e-05	0.000234	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	9e-05	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	8.97e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TERT—pancreatic cancer	8.96e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GCG—pancreatic cancer	8.96e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	8.95e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	8.93e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GCG—pancreatic cancer	8.93e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	8.88e-05	0.000227	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GCG—pancreatic cancer	8.84e-05	0.000226	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—pancreatic cancer	8.74e-05	0.000223	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.71e-05	0.000223	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.68e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TYMS—pancreatic cancer	8.63e-05	0.000221	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.6e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	8.57e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KDR—pancreatic cancer	8.56e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	8.55e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	8.54e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	8.52e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	8.43e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STK11—pancreatic cancer	8.42e-05	0.000215	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STK11—pancreatic cancer	8.39e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—pancreatic cancer	8.37e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STK11—pancreatic cancer	8.31e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KDR—pancreatic cancer	8.2e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	8.14e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	8.06e-05	0.000206	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.91e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	7.89e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	7.88e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	7.88e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	7.81e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	7.8e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGF—pancreatic cancer	7.79e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	7.72e-05	0.000197	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.59e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.57e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	7.55e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	7.55e-05	0.000193	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.5e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGF—pancreatic cancer	7.46e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	7.37e-05	0.000188	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	7.35e-05	0.000188	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.3e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	7.28e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	7.27e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	7.2e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HES1—pancreatic cancer	7.2e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	7.18e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HES1—pancreatic cancer	7.18e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HES1—pancreatic cancer	7.11e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—pancreatic cancer	7.02e-05	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	6.93e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.9e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	6.88e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	6.87e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.87e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	6.81e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	6.79e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	6.64e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	6.63e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	6.61e-05	0.000169	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.57e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	6.54e-05	0.000167	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	6.5e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CG—pancreatic cancer	6.34e-05	0.000162	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TERT—pancreatic cancer	6.31e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TERT—pancreatic cancer	6.29e-05	0.000161	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	6.23e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TERT—pancreatic cancer	6.23e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—pancreatic cancer	6.12e-05	0.000156	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	6.04e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	6.03e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	6.02e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	6.02e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	6e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	5.97e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	5.96e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	5.94e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—pancreatic cancer	5.89e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—pancreatic cancer	5.87e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—pancreatic cancer	5.81e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	5.81e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	5.79e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—pancreatic cancer	5.77e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	5.77e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—pancreatic cancer	5.75e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—pancreatic cancer	5.7e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	5.61e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CD—pancreatic cancer	5.57e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	5.56e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	5.56e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	5.52e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	5.49e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	5.47e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	5.44e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	5.42e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	5.42e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	5.41e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	5.37e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	5.37e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	5.36e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	5.32e-05	0.000136	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	5.32e-05	0.000136	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	5.32e-05	0.000136	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	5.3e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	5.3e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGF—pancreatic cancer	5.25e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	5.25e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	5.25e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	5.25e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGF—pancreatic cancer	5.24e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	5.22e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGF—pancreatic cancer	5.19e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	5.18e-05	0.000132	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	5.13e-05	0.000131	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	5.09e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	5.03e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	5e-05	0.000128	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	4.88e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CB—pancreatic cancer	4.86e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	4.84e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SRC—pancreatic cancer	4.84e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	4.83e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—pancreatic cancer	4.81e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	4.78e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	4.72e-05	0.00012	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	4.67e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	4.67e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	4.66e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	4.66e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SRC—pancreatic cancer	4.64e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.63e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.61e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	4.61e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	4.58e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.57e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	4.56e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	4.52e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	4.52e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	4.47e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	4.46e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—pancreatic cancer	4.34e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	4.33e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	4.24e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.2e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTEN—pancreatic cancer	4.2e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	4.19e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—pancreatic cancer	4.15e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.15e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	4.14e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.07e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	4.06e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.06e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.02e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	4.01e-05	0.000102	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	3.91e-05	0.0001	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	3.9e-05	9.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	3.89e-05	9.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	3.88e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	3.86e-05	9.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	3.84e-05	9.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	3.84e-05	9.81e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	3.78e-05	9.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	3.77e-05	9.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	3.75e-05	9.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	3.73e-05	9.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	3.73e-05	9.54e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	3.7e-05	9.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	3.68e-05	9.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	3.65e-05	9.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	3.64e-05	9.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.61e-05	9.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.6e-05	9.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.6e-05	9.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.57e-05	9.11e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.56e-05	9.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.54e-05	9.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.53e-05	9.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.53e-05	9.01e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.52e-05	8.99e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.51e-05	8.96e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.5e-05	8.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.47e-05	8.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.43e-05	8.77e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.42e-05	8.75e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.41e-05	8.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.41e-05	8.71e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.39e-05	8.66e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.26e-05	8.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	3.26e-05	8.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.25e-05	8.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.22e-05	8.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.18e-05	8.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.17e-05	8.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.15e-05	8.04e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.14e-05	8.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.14e-05	8.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.14e-05	8.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.13e-05	8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.11e-05	7.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.1e-05	7.92e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.01e-05	7.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.96e-05	7.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—pancreatic cancer	2.93e-05	7.47e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.92e-05	7.46e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—pancreatic cancer	2.92e-05	7.45e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	2.91e-05	7.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.89e-05	7.38e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	2.88e-05	7.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.88e-05	7.36e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.86e-05	7.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.85e-05	7.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.82e-05	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.7e-05	6.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.69e-05	6.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.67e-05	6.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.48e-05	6.34e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.48e-05	6.32e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.45e-05	6.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AKT1—pancreatic cancer	2.42e-05	6.18e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.4e-05	6.14e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.39e-05	6.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.37e-05	6.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.3e-05	5.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.29e-05	5.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.27e-05	5.79e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.03e-05	5.18e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.02e-05	5.17e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2e-05	5.12e-05	CbGpPWpGaD
